EXPLANATIONS FOR HIGH-RATES OF ERADICATION WITH TRIPLE THERAPY USING METRONIDAZOLE IN PATIENTS HARBORING METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS

Citation
Aa. Vanzwet et al., EXPLANATIONS FOR HIGH-RATES OF ERADICATION WITH TRIPLE THERAPY USING METRONIDAZOLE IN PATIENTS HARBORING METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 250-252
Citations number
24
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
ISSN journal
00664804
Volume
39
Issue
1
Year of publication
1995
Pages
250 - 252
Database
ISI
SICI code
0066-4804(1995)39:1<250:EFHOEW>2.0.ZU;2-4
Abstract
In 4 of 17 Helicobacter pylori strains obtained from antral biopsy sam ples, the registered primary resistance (MIC, >32 mu g/ml) appeared to be nonstable after prolonged microaerophilic incubation. In all resis tant strains tested, susceptibility could be obtained when culture und er normal microaerophilic conditions was preceded by a period of anaer obic incubation. Both of these findings may explain the observed discr epancy between the results of in vitro susceptibility tests and the er adication obtained in vivo.